EZH2 and nasopharyngeal carcinoma: MiR-26a was found to suppress cell growth and tumor development by inhibiting the expression of the enhancer of zeste homolog 2 (EZH2) accounting for the tumorigenesis of nasopharyngeal carcinoma [35].